About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02238886

Radical Cystectomy, Nutrition and Convalescence

The purpose of this study is to determine whether a goal directed nutritional intervention can reduce the convalescence period for patients undergoing radical cystectomy (RC). The aim is to examine t...

Lead sponsor: Rigshospitalet, Denmark•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Rigshospitalet, Denmark

The study is a randomized controlled trial. Inclusion criteria: Bladder cancer, ability to give an informed consent. Exclusion criteria: Previous radiation therapy at the pelvic area, ureterocutaneostomy or robot-assisted surgery. The intervention aims to secure that 75% of the patient's total energy and protein needs are met during hospitalization. Primary outcome: Quality of Life, using the EORTC QLQ-C30 and BLM30 questionnaire. Secondary outcomes: Body-weight, Hand Grip strength, biochemical measures, length of hospital stay, time to bowel recovery. The follow-up period is 12 weeks. Statistical analysis is performed in collaboration with a statistician.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Bladder cancer
•Ability to give an informed consent

Exclusion Criteria

•Previous radiation therapy at the pelvic area
•Ureterocutaneostomy
•Robot-assisted surgery

Related studies

RECRUITINGPhase 1

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

NCT05614739 · Urinary Bladder Neoplasms, Neoplasm Metastasis, and more

EOIB for Pain After Laparoscopic Cholecystectomy

NCT07332546 · Postoperative Pain, Laparoscopic Cholecystectomy

RECRUITINGPhase 1

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171 · Bladder Cancer, Squamous Cell Carcinoma of the Lung, and more

RECRUITINGPhase 2/3

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663 · Solid Tumor, Solid Carcinoma, and more

RECRUITINGPhase 2

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

NCT06833073 · Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2014Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment36

Start dateMay 2012

Last updatedSep 12, 2014

Condition

Urinary Bladder Neoplasms Cystectomy Bladder Cancer

Locations shown

Dep. of Urology. University Hospital Rigshospitalet, Copenhagen Denmark

Copenhagen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions